JYHB2100088 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2021-01-22 | Pharmacyclics LLC | Pharmacyclics Inc | In Review | 2021-01-21 | view |
JYHB2001826 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2020-09-19 | Pharmacyclics LLC | Pharmacyclics Inc | In Review | 2020-09-18 | view |
JYHB2000627 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2020-05-25 | Pharmacyclics LLC | Pharmacyclics Inc | Filed | 2020-06-04 | view |
JYHB2000345 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2020-04-10 | Pharmacyclics LLC | Pharmacyclics Inc | Certificate Issued | 2020-06-12 | view |
JYHB2000254 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2020-03-14 | Pharmacyclics LLC | Pharmacyclics Inc | Filed | 2020-03-26 | view |
JYHB1900203 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2019-02-22 | Pharmacyclics LLC | Pharmacyclics Inc | Certificate Issued | 2019-04-04 | view |
JYHB1800207 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs(5.1) | Supplementary Application | 2018-03-05 | Pharmacyclics LLC | Pharmacyclics Inc | Certificate Issued | 2018-11-09 | view |
JYHB1701213 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs(5.1) | Supplementary Application | 2017-09-26 | Pharmacyclics LLC | Pharmacyclics Inc | Certificate Issued | 2018-07-06 | view |
JYHB1701174 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2017-09-18 | Pharmacyclics LLC | Pharmacyclics Inc | Certificate Issued | 2018-04-18 | view |
JYHB1701171 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2017-09-11 | Pharmacyclics LLC | Pharmacyclics Inc | Filed | 2017-09-25 | view |
JXHS1600066 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs(5.1) | Import Drug Application | 2016-11-07 | Pharmacyclics LLC | Pharmacyclics Inc | Certificate Issued | 2017-08-28 | view |